$EW · Edwards Lifesciences Corp SEC Filings
Position Tracker tracks 2 SEC EDGAR filings for Edwards Lifesciences Corp ($EW) from November 4, 2026 through November 4, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 1 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
$EW 8-K — Edwards Lifesciences Corp
A broad-based beat with raised full-year guidance across sales, TAVR, TMTT, and EPS signals durable structural heart momentum.
$EW 10-Q — Edwards Lifesciences Corp
Solid top-line growth and EPS expansion are offset by a large impairment charge, making the quarter a mixed signal for investors.